As health care costs continue to rise and the burden of chronic disease grows, data-driven insights will be essential in ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...

“This limited distribution of GLUT4 in the brain is significant because it means most brain energy metabolism was traditionally thought to be insulin-independent. However, the neuroscience field ...

Maine Attorney General Aaron Frey announced a settlement agreement Tuesday with Sanofi-Aventis U.S. following scrutiny over the company’s pricing of insulin products. Sign up for our Newsletters Under ...

Hyperkalaemia, characterised by elevated potassium levels, affects 6-7% of the global population, posing severe risks to ...

over 6000 assets (including all Forex pairs, Cryptocurrencies, Commodities, Indices and US stocks) unique interbank rates extensive historic data the option to save your configuration Here below ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Here below you have a complete description of its most interesting features and benefits so you can make the most of it. The majority of other information websites display prices of a single ...

Annual recognition honors organizations committed to business integrity through robust ethics, compliance, and governance programs NORTHAMPTON, MA / ACCESS Newswire / March 11, 2025 / Medtronic, a glo ...

Corporate actions are actions taken by a company that impact the shareholders’ value directly. It is an event that brings material changes to a company and affects its stakeholders.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP Clears the way to finalize Phase 3 protocol and recruit sites for U.S.